340B Drug Pricing Program
This Court should reject Defendants’ attempt to re-litigate the merits of the case or, alternatively, to decide on their own if the 340B hospitals are entitled to relief and if so what that relief might be. Defendants’ proposal is nothing more than an attempt to further delay resolution of this…
A federal court should order the Department of Health and Human Services to "make whole" 340B hospitals that received reimbursement reductions resulting from the Centers for Medicare & Medicaid Services' 2018 outpatient prospective payment system rule, AHA and other hospital plaintiffs said…
A federal court should order the Department of Health and Human Services to “make whole” 340B hospitals that received reimbursement reductions resulting from the Centers for Medicare & Medicaid Services’ 2018 outpatient prospective payment system rule, AHA and other hospital plaintiffs said…
The American Hospital Association’s 2019 Public Policy Advocacy Agenda seeks to continue to positively influence the public policy environment for patients, communities and the health care field. We will work hand in hand with our members; the state, regional and metropolitan hospital associations…
On Dec. 27, the District Court for the District of Columbia issued an order in favor of the AHA and the other plaintiffs in the lawsuit to stop the Centers for Medicare & Medicaid Services' nearly 30 percent reduction in the reimbursement rate for 340B drugs as exceeding the statutory authority…
We’re 11 days into 2019 … we’ve returned to a divided government …and the partial government shutdown continues.
AHA commends the Centers for Medicare & Medicaid Services' willingness to address excessive growth in drug prices, but urges CMS to consider narrowing the scope of the program.